
How a drug that's killed dozens of Australians is bypassing border control
Nitazenes are dangerous synthetic opioids that carry a high risk of overdose, even in very small amounts.
At least 17 Australians have died from nitazenes since 2021.
The dangerous compound is being found in fake sleeping, anti-anxiety and pain medication pills. It is also being used in drugs like cocaine, MDMA and heroin.
But these potentially fatal drugs are evading border control, Australian Crime Intelligence Commission's (ACIC) Shane Neilson said.
Nitazenes are so strong that only a fraction of a gram can be lethal. This makes it easy to send them through the mail in parcels, and hard for border control to detect.
"The traditional serious and organised crime groups do not play a significant role, as the less sophisticated groups are bringing the drugs into the country," Mr Neilson said.
The Australian Federal Police said they intercepted eight nitazene imports at the Australian border between January 2024 and March 2025, with parcels coming from Canada, the US and Hong Kong.
Nitazenes are being mixed into drugs sold online and marketed as opiates and benzodiazepines.
Opiates provide pain relief, used legally as drugs like morphine, endone and tramadol. Benzodiazepines, also known as benzos, can reduce anxiety and aid sleep. Examples include Xanax and Valium.
Nitazenes have also been found in party drugs like MDMA (also known as ecstasy) and GHB.
"They've been identified in vape liquids, they're in tablet forms, powders, nasal sprays," ACIC's Amber Migus said.
They are easy to order from manufacturers off the internet and being so potent, a small amount can be ordered and added to a large quantity of drugs.
About three Australians die every day from an opioid-related overdose. Opiates are behind most unintentional drug deaths, followed by benzodiazepines.
The number of drug-induced deaths related to benzos doubled in the 20 years to 2022.
They are both addictive and people can develop a dependency on pharmaceutical drugs after being prescribed for legitimate reasons.
More people die from unintentional drug overdose than from road accidents, according to the Penington Institute.
Why would a drug dealer add such a dangerous compound like nitazenes to their supply, risking killing their customers?
"Drug dealers are very cynical people," Mr Neilson said.
He said evidence from the United States' opioid crisis suggests dealers might be adding nitazene to their gear to create more loyal customers.
Drug users are more dependent on the original drug, become addicted to the nitazene, and eventually dealers can sell the nitazene directly.
Australia's strict prescribing rules may be why we do not have an opioid crisis like the US, Ms Migus said.
"It means that prevention and preventative actions can work in relation to illicit drug markets," she said.
"And we're always going to be watchful in relation to synthetic opioids because potentially they're so dangerous."
While nitazenes are a growing concern for health and crime authorities, a 2021 federal government report said 70 per cent of fatal opioid overdoses in Australia involved prescribed drugs.
Health authorities encourage anyone taking an opiate legally or illegally to carry naxolone. In both nasal spray and injectable form, it reverses the effect of an opioid.
A deadly substance a thousand times stronger than heroin is bypassing customs, experts warn.
Nitazenes are dangerous synthetic opioids that carry a high risk of overdose, even in very small amounts.
At least 17 Australians have died from nitazenes since 2021.
The dangerous compound is being found in fake sleeping, anti-anxiety and pain medication pills. It is also being used in drugs like cocaine, MDMA and heroin.
But these potentially fatal drugs are evading border control, Australian Crime Intelligence Commission's (ACIC) Shane Neilson said.
Nitazenes are so strong that only a fraction of a gram can be lethal. This makes it easy to send them through the mail in parcels, and hard for border control to detect.
"The traditional serious and organised crime groups do not play a significant role, as the less sophisticated groups are bringing the drugs into the country," Mr Neilson said.
The Australian Federal Police said they intercepted eight nitazene imports at the Australian border between January 2024 and March 2025, with parcels coming from Canada, the US and Hong Kong.
Nitazenes are being mixed into drugs sold online and marketed as opiates and benzodiazepines.
Opiates provide pain relief, used legally as drugs like morphine, endone and tramadol. Benzodiazepines, also known as benzos, can reduce anxiety and aid sleep. Examples include Xanax and Valium.
Nitazenes have also been found in party drugs like MDMA (also known as ecstasy) and GHB.
"They've been identified in vape liquids, they're in tablet forms, powders, nasal sprays," ACIC's Amber Migus said.
They are easy to order from manufacturers off the internet and being so potent, a small amount can be ordered and added to a large quantity of drugs.
About three Australians die every day from an opioid-related overdose. Opiates are behind most unintentional drug deaths, followed by benzodiazepines.
The number of drug-induced deaths related to benzos doubled in the 20 years to 2022.
They are both addictive and people can develop a dependency on pharmaceutical drugs after being prescribed for legitimate reasons.
More people die from unintentional drug overdose than from road accidents, according to the Penington Institute.
Why would a drug dealer add such a dangerous compound like nitazenes to their supply, risking killing their customers?
"Drug dealers are very cynical people," Mr Neilson said.
He said evidence from the United States' opioid crisis suggests dealers might be adding nitazene to their gear to create more loyal customers.
Drug users are more dependent on the original drug, become addicted to the nitazene, and eventually dealers can sell the nitazene directly.
Australia's strict prescribing rules may be why we do not have an opioid crisis like the US, Ms Migus said.
"It means that prevention and preventative actions can work in relation to illicit drug markets," she said.
"And we're always going to be watchful in relation to synthetic opioids because potentially they're so dangerous."
While nitazenes are a growing concern for health and crime authorities, a 2021 federal government report said 70 per cent of fatal opioid overdoses in Australia involved prescribed drugs.
Health authorities encourage anyone taking an opiate legally or illegally to carry naxolone. In both nasal spray and injectable form, it reverses the effect of an opioid.
A deadly substance a thousand times stronger than heroin is bypassing customs, experts warn.
Nitazenes are dangerous synthetic opioids that carry a high risk of overdose, even in very small amounts.
At least 17 Australians have died from nitazenes since 2021.
The dangerous compound is being found in fake sleeping, anti-anxiety and pain medication pills. It is also being used in drugs like cocaine, MDMA and heroin.
But these potentially fatal drugs are evading border control, Australian Crime Intelligence Commission's (ACIC) Shane Neilson said.
Nitazenes are so strong that only a fraction of a gram can be lethal. This makes it easy to send them through the mail in parcels, and hard for border control to detect.
"The traditional serious and organised crime groups do not play a significant role, as the less sophisticated groups are bringing the drugs into the country," Mr Neilson said.
The Australian Federal Police said they intercepted eight nitazene imports at the Australian border between January 2024 and March 2025, with parcels coming from Canada, the US and Hong Kong.
Nitazenes are being mixed into drugs sold online and marketed as opiates and benzodiazepines.
Opiates provide pain relief, used legally as drugs like morphine, endone and tramadol. Benzodiazepines, also known as benzos, can reduce anxiety and aid sleep. Examples include Xanax and Valium.
Nitazenes have also been found in party drugs like MDMA (also known as ecstasy) and GHB.
"They've been identified in vape liquids, they're in tablet forms, powders, nasal sprays," ACIC's Amber Migus said.
They are easy to order from manufacturers off the internet and being so potent, a small amount can be ordered and added to a large quantity of drugs.
About three Australians die every day from an opioid-related overdose. Opiates are behind most unintentional drug deaths, followed by benzodiazepines.
The number of drug-induced deaths related to benzos doubled in the 20 years to 2022.
They are both addictive and people can develop a dependency on pharmaceutical drugs after being prescribed for legitimate reasons.
More people die from unintentional drug overdose than from road accidents, according to the Penington Institute.
Why would a drug dealer add such a dangerous compound like nitazenes to their supply, risking killing their customers?
"Drug dealers are very cynical people," Mr Neilson said.
He said evidence from the United States' opioid crisis suggests dealers might be adding nitazene to their gear to create more loyal customers.
Drug users are more dependent on the original drug, become addicted to the nitazene, and eventually dealers can sell the nitazene directly.
Australia's strict prescribing rules may be why we do not have an opioid crisis like the US, Ms Migus said.
"It means that prevention and preventative actions can work in relation to illicit drug markets," she said.
"And we're always going to be watchful in relation to synthetic opioids because potentially they're so dangerous."
While nitazenes are a growing concern for health and crime authorities, a 2021 federal government report said 70 per cent of fatal opioid overdoses in Australia involved prescribed drugs.
Health authorities encourage anyone taking an opiate legally or illegally to carry naxolone. In both nasal spray and injectable form, it reverses the effect of an opioid.
A deadly substance a thousand times stronger than heroin is bypassing customs, experts warn.
Nitazenes are dangerous synthetic opioids that carry a high risk of overdose, even in very small amounts.
At least 17 Australians have died from nitazenes since 2021.
The dangerous compound is being found in fake sleeping, anti-anxiety and pain medication pills. It is also being used in drugs like cocaine, MDMA and heroin.
But these potentially fatal drugs are evading border control, Australian Crime Intelligence Commission's (ACIC) Shane Neilson said.
Nitazenes are so strong that only a fraction of a gram can be lethal. This makes it easy to send them through the mail in parcels, and hard for border control to detect.
"The traditional serious and organised crime groups do not play a significant role, as the less sophisticated groups are bringing the drugs into the country," Mr Neilson said.
The Australian Federal Police said they intercepted eight nitazene imports at the Australian border between January 2024 and March 2025, with parcels coming from Canada, the US and Hong Kong.
Nitazenes are being mixed into drugs sold online and marketed as opiates and benzodiazepines.
Opiates provide pain relief, used legally as drugs like morphine, endone and tramadol. Benzodiazepines, also known as benzos, can reduce anxiety and aid sleep. Examples include Xanax and Valium.
Nitazenes have also been found in party drugs like MDMA (also known as ecstasy) and GHB.
"They've been identified in vape liquids, they're in tablet forms, powders, nasal sprays," ACIC's Amber Migus said.
They are easy to order from manufacturers off the internet and being so potent, a small amount can be ordered and added to a large quantity of drugs.
About three Australians die every day from an opioid-related overdose. Opiates are behind most unintentional drug deaths, followed by benzodiazepines.
The number of drug-induced deaths related to benzos doubled in the 20 years to 2022.
They are both addictive and people can develop a dependency on pharmaceutical drugs after being prescribed for legitimate reasons.
More people die from unintentional drug overdose than from road accidents, according to the Penington Institute.
Why would a drug dealer add such a dangerous compound like nitazenes to their supply, risking killing their customers?
"Drug dealers are very cynical people," Mr Neilson said.
He said evidence from the United States' opioid crisis suggests dealers might be adding nitazene to their gear to create more loyal customers.
Drug users are more dependent on the original drug, become addicted to the nitazene, and eventually dealers can sell the nitazene directly.
Australia's strict prescribing rules may be why we do not have an opioid crisis like the US, Ms Migus said.
"It means that prevention and preventative actions can work in relation to illicit drug markets," she said.
"And we're always going to be watchful in relation to synthetic opioids because potentially they're so dangerous."
While nitazenes are a growing concern for health and crime authorities, a 2021 federal government report said 70 per cent of fatal opioid overdoses in Australia involved prescribed drugs.
Health authorities encourage anyone taking an opiate legally or illegally to carry naxolone. In both nasal spray and injectable form, it reverses the effect of an opioid.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


7NEWS
an hour ago
- 7NEWS
Meet the best-selling steam inhalers that are battling flu and cold season: ETTO Australia
Cold and flu season is here — but relief is closer than you think. One time-tested method that thousands of Australians swear by is steam therapy, known for easing congestion and calming cold symptoms like blocked sinuses and headaches. ETTO Australia's F orest Lungs Steam Inhalers offer a modern take on this age-old remedy. Just drop one into a bowl of hot water, place a towel over your head, and breathe deeply to let the steam open your airways. Crafted from naturally sourced Australian Blue Mallee Eucalyptus and menthol, the refreshing scent helps to clear nasal passages — no matter what stage of a cold you're in. Perfect for travel and having on hand all year round, you can take 15 per cent off these customer favourites. Down to $32 from $38, stock up before this game-changing dea l for the cold winter months comes to an end. Steam therapy is a traditional and commonly prescribed remedy by doctors thanks to its ability to loosen and thin mucus and moisturise congested breathing passages. ETTO's Forest Lungs Steam Inhalers are one of the brands best-selling products, and are a game-changer for those with sinus and congestion related issues. Theses steam inhalers are perfect for anyone for wants to do the following: Studies show that over 90 per cent of the Eucalyptus oil used in Australia actually comes from overseas. ETTO Australia is proud to grow botanical oils such as Australian Tea Tree and Blue Mallee Eucalyptus in the natural surroundings of their own farms in New South Wales and Western Australia. They are able to steam and distil leaves to extract potent concentrations of key phytochemicals, which are then paired with plant-based extracts by bio-chemists to create hard-working formulas. 'I have had chronic ENT issues for my entire life and ETTO's steam inhaler is by far the best product I have ever used. It works! It is the highest quality and my order arrived really quickly. I'm buying the ETTO range for all my family,' one shopper commented. ' The steam opened up my lungs allowing for deeper, healthier breathing which was the biggest surprise to me as I have been using Ventolin daily since forever due to my asthma and had never felt this level of relief,' another added. 'I used one post a long haul flight to help clear my congestion. It smelt lovely and helped to clear my stuffy head. It was also just calming to do. The smell is definitely superior to other eucalyptus I've tried,' a third wrote.


Perth Now
3 hours ago
- Perth Now
Health headlines dying stages of election campaign
Health has dominated the final days of Tasmania's snap election campaign, as major parties try to get undecided voters on board. The island state is heading to the ballot box on Saturday for a second election in as many years after minority Liberal premier Jeremy Rockliff lost the confidence of parliament in June. All signs point to another hung parliament, with the latest poll putting the Liberals ahead of Labor but both short of the 18-seat mark needed to reach majority. Tasmania's health outcomes lag behind national averages on many metrics, with life expectancy the second worst of any Australian jurisdiction. An ageing population and socio-economic disadvantage put significant pressure on the health system, according to a Primary Health Tasmania 2024 report. Mr Rockliff says the Liberals would deliver a purpose-built $15 million medical precinct, including a mental health hub, in the Huon Valley south of Hobart. It would feature 100 per cent bulk-billing GP appointments, as well as after-hours and weekend services. Labor leader Dean Winter was in Launceston in the state's north to reveal the location of one of its 10 proposed TassieDoc bulk-billed GP clinics. His party doubled their TassieDoc commitment to 10 clinics, after the Liberals matched their initial commitment to set up five clinics. "It takes an election campaign and sensible policies to see them do anything about health," Mr Winter told reporters. The state's rural doctors association has called for urgent action to address an "exorbitant" budget spend in the northwest on locum services. Some $3.7 million per year could be saved if the health service permanently recruited GP emergency and GP anaesthetics instead of using locums, the association said. The two party leaders, who have both made health announcements in recent days, will go head-to-head in the only debate of the campaign on Wednesday. The Liberals hold 14 of 35 seats in the lower house, while the 11-year Labor opposition has 10. The no-confidence motion in Mr Rockliff, put forward by Labor and supported by the Greens and three crossbench MPs, was critical of the state's ballooning debt.


West Australian
4 hours ago
- West Australian
First Nations hepatitis B risks revealed in study
The impacts to liver health from a unique strain of chronic hepatitis B, which predominantly affects First Nations people, have been revealed in a study. Analysing the C4 hepatitis B strain among Aboriginal and Torres Strait Islander people, researchers from Menzies School of Health Research, found a severe type of liver disease among those living with the infection. "The things we worry about when people have hepatitis b as a chronic infection, if they get liver damage, which can progress to liver cirrhosis or liver failure and they are also at higher risk of liver cancer," study lead and Menzies Hepatitis B program lead Jane Davies told AAP. "This C4 sub-genotype, when we looked at it in the lab at the very detailed genetics of it, it looked like it was very aggressive with respect to these two things." The study confirmed the lab findings by analysing clinical data from more than 780 people across the Northern Territory, Professor Davies said. She said 22 per cent of people in this cohort had significant liver damage, and 16 per cent of those had cirrhosis, which is severe scarring on the liver, which can cause problems with the organ's functioning. "We've followed people over time, we've looked at different markers of the virus as part of their clinical care and have confirmed there is significantly high rates of liver damage within the population of Aboriginal and Torres Strait Islander people who have this very specific sub-genotype of chronic hepatitis B," Prof Davies said. Under current Australian guidelines 25 per cent of the cohort studied are receiving treatment, Prof Davies said. Researchers explored the potential impact of using World Health Organisation expanded treatment guidelines for people living with C4 hepatitis B. Prof Davies said under the expanded guidelines half of those not currently being treated would be eligible for treatment. While expanding the guidelines is a nuanced conversation, Prof Davies said, she believes it is common sense to do everything possible to support healthy liver function for those living with hepatitis B. "My personal opinion is that we should be treating as many people as we can where there is evidence that we can reduce their risk of progression to liver failure and liver cancer," she said. "That's where the really crucial question comes - is there evidence in this in this very specific sub-genotype in out setting that we should be immediately rolling out treatment to this more than roughly 50 per cent of people. "That's definitely a nuances conversation with pros and cons." The study, representing the latest findings from the Hep B PAST program, which aims to eliminate hepatitis B in the NT, was published in BMC Infectious Diseases .